Corbus Pharmaceuticals Holdings Inc. shares rise Wednesday, outperforming market

Corbus Pharmaceuticals Holdings Inc.CRBP shares,
+ 10.88%
rose 10.88% to $ 3.42 on Wednesday, in what turned out to be a mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA
+ 0.20%
up 0.20% to 31,437.80 and the NASDAQ COMP Composite Index,
falling 0.25% to 13,972.53. This was the stock’s third consecutive day of earnings. Corbus Pharmaceuticals Holdings Inc. closed $ 6.37 below its 52-week high ($ 9.78), which the company achieved on Aug. 31.

The stock outperformed some of its competitors on Wednesday, as Fate Therapeutics Inc. FATE,
fell 1.91% to $ 103.31, Vanda Pharmaceuticals Inc. VNDA,
fell 0.58% to $ 15.41, and Viking Therapeutics Inc. VKTX,
fell 2.09% to $ 8.89. The trading volume (66.0M) eclipsed its 50-day median volume of 12.8M.

Editor’s Note: This story was automatically generated by Automated Insights using data from Dow Jones and FactSet. See our terms of use for market data.


Source link